Overview
Status
Active
Registry date
2005-01-31
Share capital
50,000.00 PLN
Registered address
Staszica 1, 63-100 Śrem, Poland
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2020, 125 days late).
- 202514/07/2026
- 202412/06/2025
- 202309/07/2024
- 202207/04/2023
- 202119/04/2022
- 202017/02/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 451.19kMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD -13.62kMedianUSD 20.66kAverageUSD 86.62k
Operating costs
This companyUSD 463.96kMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 50.22kMedianUSD 544.32kAverageUSD 1.76m
Industry
Authorized Representatives
Justyna Maria Kolińska – Management Board Member
Karolina Zegan – President of the Management Board
Manner of representation
Each member of the management board is authorised to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Justyna Maria Kolińskaage 43 | 50 | $6,753.11 | 50% |
Karolina Zeganage 32 | 50 | $6,753.11 | 50% |
Beneficial owners
No beneficial owners recorded for the company Apteka Odlewnik.
Bank accounts
Registered as a VAT taxpayer on 2005-05-24.
16 1090 1405 0000 0001 0396 3768
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $11,162.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,157$1,157 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,157$1,157 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 8, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $7,693$7,693 | Polski Fundusz Rozwoju S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Produkcyjno-Handlowe Apimexsp. z o.o. | $16,601,428.28 | apimex.pl | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl | ||
| Gold Lionsp. z o.o. | $1,669,649.21 | goldlion.pl | ||
| Grupa Aptekarska Kujałowiczsp. j. | $1,452,484.91 | wga.pl | ||
| Twoja Tania Apteka Farmarsp. z o.o. | $440,843.57 | domlekow.pl | ||
| Nukloversp. z o.o. | $227,479.26 | nuklover.com | ||
| Massmedsp. z o.o. | $49,747.70 | mojoapps.co | ||
| Pharmer Polskasp. z o.o. | $15,884.06 | punktapteczny.online | ||
| DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A. | $2,740.83 | kwendasa.pl | ||
| Rutkiewicz I Wspólnicysp. j. | – | aptekapoznan.com |
Change history
| Date | Event | |
|---|---|---|
| 2022-02-10 | Switch to PKD 2007 (10 PKD 2004 codes → 8 PKD 2007 codes) | |
| 2005-01-31 | Entered in the register |
FAQ
The main business activity of Apteka Odlewnik focuses on dispensing chemist in specialised stores.
The company was registered in the Polish National Court Register (KRS) on January 31, 2005.
The headquarters is located at: Staszica 1, 63-100 Śrem.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $420,271, representing an increase of 12.6% compared to 2023.
Yes, in 2024 the company was profitable, achieving a net profit of $511.
The largest operating cost category falls under other operating costs. This category amounted to $344,822 in 2024, representing 83% of all operating expenses.
Last updated: 2026-07-17